Citation: N. Najafian et al., T cell costimulatory blockade as a novel immune intervention in autoimmunediseases, CLIN DERMAT, 19(5), 2001, pp. 586-591
Citation: K. Makhlouf et al., Increased percentage of IL-12+monocytes in the blood correlates with the presence of active MRI lesions in MS, J NEUROIMM, 119(1), 2001, pp. 145-149
Authors:
Makhlouf, K
Comabella, M
Imitola, J
Weiner, HL
Khoury, SJ
Citation: K. Makhlouf et al., Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis, J NEUROIMM, 117(1-2), 2001, pp. 156-165
Authors:
Frank, MH
Denton, MD
Alexander, SI
Khoury, SJ
Sayegh, MH
Briscoe, D
Citation: Mh. Frank et al., Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro, J IMMUNOL, 166(4), 2001, pp. 2451-2459
Authors:
Chitnis, T
Najafian, N
Benou, C
Salama, AD
Grusby, MJ
Sayegh, MH
Khoury, SJ
Citation: T. Chitnis et al., Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis, J CLIN INV, 108(5), 2001, pp. 739-747
Authors:
Waaga, AM
Gasser, M
Kist-van Holthe, JE
Najafian, N
Muller, A
Vella, JP
Womer, KL
Chandraker, A
Khoury, SJ
Sayegh, MH
Citation: Am. Waaga et al., Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo, J CLIN INV, 107(7), 2001, pp. 909-916
Authors:
Weiner, HL
Guttmann, CRG
Khoury, SJ
Orav, EJ
Hohol, MJ
Kikinis, R
Jolesz, FA
Citation: Hl. Weiner et al., Serial magnetic resonance imaging in multiple sclerosis: correlation with attacks, disability, and disease stage, J NEUROIMM, 104(2), 2000, pp. 164-173
Authors:
Kishimoto, K
Dong, VM
Issazadeh, S
Fedoseyeva, EV
Waaga, AM
Yamada, A
Sho, M
Benichou, G
Auchincloss, H
Grusby, MJ
Khoury, SJ
Sayegh, MH
Citation: K. Kishimoto et al., The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulatingallogeneic Th1 and Th2 responses in vivo, J CLIN INV, 106(1), 2000, pp. 63-72
Authors:
Issazadeh, S
Abdallah, K
Chitnis, T
Chandraker, A
Wells, AD
Turka, LA
Sayegh, MH
Khoury, SJ
Citation: S. Issazadeh et al., Role of passive T-cell death in chronic experimental autoimmune encephalomyelitis, J CLIN INV, 105(8), 2000, pp. 1109-1116
Authors:
Khoury, SJ
Guttmann, CRG
Orav, EJ
Kikinis, R
Jolesz, FA
Weiner, HL
Citation: Sj. Khoury et al., Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis, ARCH NEUROL, 57(8), 2000, pp. 1183-1189
Authors:
Hohol, MJ
Olek, MJ
Orav, EJ
Stazzone, L
Hafler, DA
Khoury, SJ
Dawson, DM
Weiner, HL
Citation: Mj. Hohol et al., Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: Response to therapy is linked to the duration of progressive disease, MULT SCLER, 5(6), 1999, pp. 403-409
Authors:
Schaub, M
Issazadeh, S
Stadlbauer, THW
Peach, R
Sayegh, MH
Khoury, SJ
Citation: M. Schaub et al., Costimulatory signal blockade in murine relapsing experimental autoimmune encephalomyelitis, J NEUROIMM, 96(2), 1999, pp. 158-166
Authors:
Khoury, SJ
Orav, EJ
Guttmann, CRG
Kikinis, R
Jolesz, FA
Weiner, HL
Citation: Sj. Khoury et al., Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis, NEUROLOGY, 53(4), 1999, pp. 758-764
Authors:
Issazadeh, S
Zhang, M
Sayegh, MH
Khoury, SJ
Citation: S. Issazadeh et al., Acquired thymic tolerance: Role of CTLA4 in the initiation and maintenanceof tolerance in a clinically relevant autoimmune disease model, J IMMUNOL, 162(2), 1999, pp. 761-765